Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or South Carolina for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to South Carolina only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. South Carolina (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Eric Jablon (NPI 1215042569)

Field	Value
Entity Type	Individual
Organization	Eric Jablon
Address	3531 Mary Ader Ave
City	Charleston
State	SC
ZIP	29414
Taxonomy	Ophthalmology Physician
NPI Enumerated	August 20, 2006

Payer Source	Total Paid
Medicare	$8.9M
Medicaid	$0

Key Findings

The provider's billing is effectively single-payer in this dataset: Total Medicare revenue is $8.9M and there is no Medicaid billing on file. This means Medicare dominates the public-payer footprint and there is no state Medicaid activity to evaluate for in-state payer comparisons or contracting implications.

Revenue is highly concentrated in a small set of drug codes: the precomputed top 3 Medicare codes account for 72.1% of this provider's total Medicare revenue, specifically J0178 ($4.9M, 55.0%), J3490 ($918.6K, 10.3%), and J2781 ($601.2K, 6.8%). J0178 alone represents a majority share of reported Medicare dollars, signaling critical dependence on a single high-revenue injectable.

Code mix and service line strongly indicate a retina-focused ophthalmology operation: high-revenue injectable codes (J0178, J2781, J2778, J2777, J2778) combined with high-volume retinal imaging (92134, 92235, 92250) and vitreoretinal procedures (67028, 67042) point to routine intravitreal pharmacotherapy, frequent diagnostic retinal imaging, and procedural treatment of retinal disease.

The provider is a national-volume outlier for several core retina services and drugs: J0178 ranks #6 of 3204 providers nationally (100th percentile; extreme outlier) and J2781 ranks #5 of 490 providers nationally (99th percentile; extreme outlier). Additional high-volume codes with extreme-outlier status include 67028 (rank #19 of 4255, 100th percentile; extreme outlier) and imaging codes such as 92134 (rank #74 of 26868, 100th percentile; extreme outlier), indicating dominant activity versus national peers for injections and retinal imaging.

Operational economics show a dual pattern of very high claim counts for lower-paid procedure codes alongside high-dollar drug reimbursement: examples include 67028 with 4.2K claims at $95 avg paid/claim ($401.6K revenue) and 92134 with 4.6K claims at $28 avg paid/claim ($128.7K), while drug codes like J0178 ($693 avg paid/claim) and J3490 ($1770 avg paid/claim) drive the largest single-dollar totals. This mix suggests throughput-focused infusion/injection workflows supporting revenue that is concentrated in costly biologics and specialty injectables.

Long tenure in the public enrollment data: NPI enumerated 2006-08-20 (~20 years ago), which supports interpretation of these volumes as the output of an established practice rather than a short-term outlier or new entrant. The long enumeration increases the likelihood that reported high volumes reflect sustained clinical focus and referral patterns.

From a payer risk and contracting perspective, the heavy dependence on a few drug codes (top 3 = 72.1% of Medicare revenue) creates programmatic sensitivity: changes in access, reimbursement, or preferred-product policies for J0178 and J2781 could materially affect this provider's Medicare revenue. The absence of any Medicaid billing on file further concentrates commercial/public revenue exposure into Medicare and non-Medicaid sources, limiting state Medicaid leverage for utilization management.

Ranking labels show important nuances for analysts: some large-dollar items are flagged as 'typical, unremarkable' (for example J3490: 519 claims, $1770 avg paid/claim, $918.6K revenue; rank #105 of 2838 providers nationally, 96th percentile; typical, unremarkable), while other codes are explicitly 'extreme outlier' or 'notably above typical' (for example J7312 rank #32 of 492 providers nationally, 93th percentile; notably above typical). Analysts should therefore weigh both raw claim and revenue counts and the provided ranking labels when assessing competitive standing and utilization patterns.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

25 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	7,050	$690	$4.9M
J3490	Unclassified drugs	520	$1,770	$918.6K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	5,010	$120	$601.2K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	2,170	$220	$470.9K
J2778	Injection, ranibizumab, 0.1 mg	2,260	$180	$412.8K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	4,230	$100	$401.6K
J2777	Injection, faricimab‑svoa, 0.1 mg	10,620	$30	$308K
J3590	Unclassified biologics	60	$2,110	$132.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	2,110	$60	$130.5K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	4,600	$30	$128.7K

Showing 1–10 of 25

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. South Carolina Distribution

Eric Jablon — 13 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — South Carolina

Full comparison — all codes billed, vs. state median

25 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	1	50	970	$690	$1.1M
J2777	25	40	15,960	$30	$594.7K
J2778	9	30	1,440	$180	$337.4K
Q5128	2	10	1,150	$220	$273.3K
J2781	1	20	720	$120	$128K
67028	1	50	1,140	$90	$110.3K
J3590	1	10	60	$1,650	$84.4K
J3490	2	50	70	$510	$57.7K
J7312	1	10	320	$150	$51K
67036	8	20	20	$1,110	$40.1K

Showing 1–10 of 25

Related Providers

Other providers that share a Tax Identification Number (TIN) with Eric Jablon, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Stephen Phillips	SC	Ophthalmology Physician	$5M	$0
John Kerrison	SC	Ophthalmology Physician	$5M	$0
Charleston Neurosciences Institute	SC	Ophthalmology Physician	$0	$4.2M
Daniel Alfaro	SC	Ophthalmology Physician	$3.6M	$0
Michael Johnson	SC	Ophthalmology Physician	$3M	$0
Mona Camacci	SC	Ophthalmology Physician	$1.1M	$0
Scott Anfinson	SC	Ophthalmology Physician	$775.5K	$0
John Chancellor	TX	Ophthalmology Physician	$647.3K	$0
Robert Brame	SC	Ophthalmology Physician	$560.6K	$0

Nearby Providers

Other providers in the same ZIP code as Eric Jablon, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
South Carolina Dept Of Mental Health Accounting Office	SC	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$65.9M
Bon Secours St. Francis Xavier Hospital Inc.	SC	General Acute Care Hospital	$0	$35.9M
Coastal Pediatric Associates, P.A.	SC	Pediatrics Physician	$0	$25M
Charleston Ent Associates, LLC	SC	Otolaryngology Physician	$0	$7.1M
Physicians Eye Surgery Center LLC	SC	Ambulatory Surgical Clinic/Center	$3.9M	$70.1K
Bon Secours St Francis Xavier Hospital, Inc.	SC	Emergency Medicine Physician	$0	$2.3M
Charleston Endoscopy Center	SC	Ambulatory Surgical Clinic/Center	$1.6M	$434.5K
Lowrey King	SC	Ophthalmology Physician	$1.3M	$0
Palmetto Endoscopy Center LLC	SC	Ambulatory Surgical Clinic/Center	$684.7K	$105.5K
Saima Ismaili	SC	Podiatrist	$683K	$0

Eric Jablon — Billing Profile & Reimbursement Data

Sign up for Eric Jablon — Billing Profile & Reimbursement Data policy alerts

Eric Jablon — Billing Profile & Reimbursement Data

Sign up for Eric Jablon — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References